FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2786230345> ?p ?o ?g. }

• W2786230345 endingPage "20" @default.
• W2786230345 startingPage "7" @default.
• W2786230345 abstract "A series of 1,4-substituted arylalkyl piperazine derivatives were synthesized and studied with the aim to obtain potent P-gp-dependent multidrug-resistant (MDR) reversers. The new compounds were designed on the basis of the structures of our previous arylamine ester derivatives endowed with high P-gp-dependent multidrug resistance reversing activity. All new compounds were active in the pirarubicin uptake assay on the doxorubicin–resistant erythroleukemia K562 cells (K562/DOX). In particular, compounds bearing methoxy aromatic moieties showed fairly high reversal activities. The most potent compounds, 8, 9, 10 and 13, were further studied by evaluating their doxorubicin cytotoxicity enhancement (reversal fold, RF) and the inhibition of P-gp-mediated rhodamine-123 (Rhd 123) efflux on the K562/DOX cell line. The results of all pharmacological assays indicated that the combination of a basic piperazine scaffold with arylalkyl residues allowed us to obtain very interesting P-gp modulating compounds. Two long-lasting P-gp pump modulators (9 and 10) were identified; they were able to inhibit remarkably the P-gp substrate rhodamine-123 efflux on the resistant K562/DOX cell line after 60 min. Overall compound 9 appeared the most promising compound being a potent and long-lasting P-gp–dependent MDR modulator." @default.
• W2786230345 created "2018-02-23" @default.
• W2786230345 creator A5003820375 @default.
• W2786230345 creator A5007182721 @default.
• W2786230345 creator A5027182354 @default.
• W2786230345 creator A5044635551 @default.
• W2786230345 creator A5046381036 @default.
• W2786230345 creator A5065855691 @default.
• W2786230345 creator A5081793175 @default.
• W2786230345 creator A5091828318 @default.
• W2786230345 date "2018-03-01" @default.
• W2786230345 modified "2023-10-13" @default.
• W2786230345 title "Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents" @default.
• W2786230345 cites W130020229 @default.
• W2786230345 cites W1965455284 @default.
• W2786230345 cites W1967467094 @default.
• W2786230345 cites W1970346993 @default.
• W2786230345 cites W1971866641 @default.
• W2786230345 cites W1981140460 @default.
• W2786230345 cites W1984306631 @default.
• W2786230345 cites W1986663325 @default.
• W2786230345 cites W1992237854 @default.
• W2786230345 cites W1996945686 @default.
• W2786230345 cites W1999584419 @default.
• W2786230345 cites W2011495430 @default.
• W2786230345 cites W2016377328 @default.
• W2786230345 cites W2024306434 @default.
• W2786230345 cites W2025635891 @default.
• W2786230345 cites W2026398446 @default.
• W2786230345 cites W2038210417 @default.
• W2786230345 cites W2045032952 @default.
• W2786230345 cites W2049683781 @default.
• W2786230345 cites W2053086725 @default.
• W2786230345 cites W2053848658 @default.
• W2786230345 cites W2055301650 @default.
• W2786230345 cites W2059973185 @default.
• W2786230345 cites W2062782200 @default.
• W2786230345 cites W2063837793 @default.
• W2786230345 cites W2068801152 @default.
• W2786230345 cites W2075747570 @default.
• W2786230345 cites W2090651436 @default.
• W2786230345 cites W2119010359 @default.
• W2786230345 cites W2123869439 @default.
• W2786230345 cites W2125074900 @default.
• W2786230345 cites W2152546397 @default.
• W2786230345 cites W2207885398 @default.
• W2786230345 cites W2322225126 @default.
• W2786230345 cites W2397903553 @default.
• W2786230345 cites W2412450279 @default.
• W2786230345 cites W2578534622 @default.
• W2786230345 cites W2767184029 @default.
• W2786230345 cites W796154648 @default.
• W2786230345 doi "https://doi.org/10.1016/j.ejmech.2018.01.092" @default.
• W2786230345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29421572" @default.
• W2786230345 hasPublicationYear "2018" @default.
• W2786230345 type Work @default.
• W2786230345 sameAs 2786230345 @default.
• W2786230345 citedByCount "13" @default.
• W2786230345 countsByYear W27862303452019 @default.
• W2786230345 countsByYear W27862303452020 @default.
• W2786230345 countsByYear W27862303452021 @default.
• W2786230345 countsByYear W27862303452022 @default.
• W2786230345 countsByYear W27862303452023 @default.
• W2786230345 crossrefType "journal-article" @default.
• W2786230345 hasAuthorship W2786230345A5003820375 @default.
• W2786230345 hasAuthorship W2786230345A5007182721 @default.
• W2786230345 hasAuthorship W2786230345A5027182354 @default.
• W2786230345 hasAuthorship W2786230345A5044635551 @default.
• W2786230345 hasAuthorship W2786230345A5046381036 @default.
• W2786230345 hasAuthorship W2786230345A5065855691 @default.
• W2786230345 hasAuthorship W2786230345A5081793175 @default.
• W2786230345 hasAuthorship W2786230345A5091828318 @default.
• W2786230345 hasBestOaLocation W27862303452 @default.
• W2786230345 hasConcept C109316439 @default.
• W2786230345 hasConcept C121332964 @default.
• W2786230345 hasConcept C133936738 @default.
• W2786230345 hasConcept C171122931 @default.
• W2786230345 hasConcept C178790620 @default.
• W2786230345 hasConcept C185592680 @default.
• W2786230345 hasConcept C200082930 @default.
• W2786230345 hasConcept C202751555 @default.
• W2786230345 hasConcept C2776201271 @default.
• W2786230345 hasConcept C2776694085 @default.
• W2786230345 hasConcept C2778589691 @default.
• W2786230345 hasConcept C2778707650 @default.
• W2786230345 hasConcept C2779916640 @default.
• W2786230345 hasConcept C2781303535 @default.
• W2786230345 hasConcept C501593827 @default.
• W2786230345 hasConcept C54355233 @default.
• W2786230345 hasConcept C55493867 @default.
• W2786230345 hasConcept C62520636 @default.
• W2786230345 hasConcept C71240020 @default.
• W2786230345 hasConcept C81885089 @default.
• W2786230345 hasConcept C86803240 @default.
• W2786230345 hasConcept C91881484 @default.
• W2786230345 hasConcept C98274493 @default.
• W2786230345 hasConceptScore W2786230345C109316439 @default.
• W2786230345 hasConceptScore W2786230345C121332964 @default.

• next